These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 156581)

  • 1. Cultured human leukemic non-T/non-B lymphoblasts and their stimulating capacity in "one-way" mixed lymphocyte reaction: suggestive evidence for early T-cell or B-cell precursors.
    Han T; Dadey B; Minowada J
    Cancer; 1979 Jul; 44(1):136-40. PubMed ID: 156581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of stimulating capacity of mixed lymphocyte reaction (MLR-S) as a possible marker for the cell-origin of null-cell acute lymphoblastic leukaemia.
    Han T; Minowada J
    Immunology; 1978 Aug; 35(2):333-9. PubMed ID: 155647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique leukemic non-T/non-B lymphoid cell lines (REH and KM-3): absence of MLR-S and presence of suppressor cell activity for normal T-cell response.
    Han T; Dadey B; Minowada J
    J Clin Lab Immunol; 1978 Nov; 1(3):237-43. PubMed ID: 159361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
    Han T; Gomez GA; Minowada J
    Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparity of mixed lymphocyte reactivity to cultured cells of human T and B lymphoid lines.
    Pauly JL; Minowada J; Han T; Moore GE
    J Natl Cancer Inst; 1975 Mar; 54(3):557-62. PubMed ID: 123598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor mixed lymphocyte reaction stimulatory capacity of leukemic B cells of chronic lymphocytic leukemia patients despite the presence of Ia antigens.
    Halper JP; Fu SM; Gottlieb AB; Winchester RJ; Kunkel HG
    J Clin Invest; 1979 Nov; 64(5):1141-8. PubMed ID: 159311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of mixed lymphocyte reactions, surface B cell antigens, and intracytoplasmic immunoglobulins in "null cell" acute lymphocytic leukemia.
    Davey FR; Dock NL; Wolos JA; Terzian JA; Gottlieb AJ
    Cancer; 1979 Nov; 44(5):1622-8. PubMed ID: 159120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the stimulating capacity of human leukemia T-cell, null cell, and B-cell lines in mixed lymphoma culture.
    Tsubota T; Miyoshi I; Uno J; Hiraki S; Kimura I
    J Natl Cancer Inst; 1978 Apr; 60(4):793-5. PubMed ID: 147348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulating capacity of fresh and cultured human leukaemic lymphoid and myeloid cells in 'one-way' mixed lymphocyte reaction.
    Han T; Dadey B; Minowada J
    Immunology; 1977 Oct; 33(4):543-51. PubMed ID: 144702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human myeloma cells and their strong stimulating capacity in 'one-way' mixed lymphocyte reaction: a comparative study with leukaemic B lymphoid cells.
    Han T; Dadey B; Minowada J; Golde DW
    Immunology; 1979 Sep; 38(1):63-8. PubMed ID: 159862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line.
    Gougos A; Letarte M
    J Immunol; 1988 Sep; 141(6):1925-33. PubMed ID: 3262644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface markers and prognostic factors in acute lymphoblastic leukemia.
    Tsukimoto I; Wong KY; Lampkin BC
    N Engl J Med; 1976 Jan; 294(5):245-8. PubMed ID: 53789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unique surface marker profile in T-cell acute lymphocytic leukemia.
    Richie ER; Sullivan MP; van Eys J
    Blood; 1980 Apr; 55(4):702-5. PubMed ID: 6444535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro functional studies of mononuclear cells in patients with CLL: evidence for functionally normal T lymphocytes and monocytes and abnormal B lymphocytes.
    Han T; Dadey B
    Cancer; 1979 Jan; 43(1):109-17. PubMed ID: 153786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of cultured human T-cell lymphoid lines to stimulate in mixed leukocyte culture.
    Royston I; Graze PR; Pitts RB
    J Natl Cancer Inst; 1974 Aug; 53(2):361-7. PubMed ID: 4276467
    [No Abstract]   [Full Text] [Related]  

  • 16. Ia+T10+ blast cells in acute lymphoblastic leukaemia are precursors of T+ and B+ cells.
    Miljković AK; Isaković K; Matejić T; Stojanović B
    Adv Exp Med Biol; 1985; 186():1017-25. PubMed ID: 3931426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two E-rosette-forming lymphoid cell lines.
    Morikawa S; Tatsumi E; Baba M; Harada T; Yasuhira K
    Int J Cancer; 1978 Feb; 21(2):166-70. PubMed ID: 203546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the stimulating capacity of human leukemic REH cells in a mixed lymphocyte culture.
    Hartwig M
    Biomed Biochim Acta; 1986; 45(5):K5-7. PubMed ID: 2944514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte transformation induced by autologous cells.
    Weksler ME; Kuntz MM; Birnbaum G; Innes JB
    Fed Proc; 1978 Aug; 37(10):2370-3. PubMed ID: 79505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabbit antiserum against a non-T, non-B leukemia cell line that carries the Ph1 chromosome (NALM-1): antibody specific to a non-T, non-B acute lymphoblastic leukemia antigen.
    Koshiba H; Minowada J; Pressman D
    J Natl Cancer Inst; 1978 Oct; 61(4):987-91. PubMed ID: 81309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.